-
公开(公告)号:US20090271896A1
公开(公告)日:2009-10-29
申请号:US11835237
申请日:2007-08-07
申请人: Ajith Anand , Kirankumar Mysore
发明人: Ajith Anand , Kirankumar Mysore
CPC分类号: C12N15/8205 , C12N2770/00023
摘要: The invention provides methods and compositions for enhancing the efficiency of Agrobacterium-mediated transformation of host cells such as plant cells. Plant expression constructs comprising a gene encoding a VIP2 or VIP2-like polypeptide are provided, as well as methods for utilizing such constructs to enhance Agrobacterium-mediated transformation efficiency.
摘要翻译: 本发明提供用于提高农杆菌介导的宿主细胞如植物细胞转化效率的方法和组合物。 提供了包含编码VIP2或VIP2样多肽的基因的植物表达构建体,以及利用这些构建体来提高农杆菌介导的转化效率的方法。
-
公开(公告)号:US20090029441A1
公开(公告)日:2009-01-29
申请号:US12090579
申请日:2006-11-01
申请人: Qian Wang , Zhongwel Niu
发明人: Qian Wang , Zhongwel Niu
IPC分类号: C12N7/00
CPC分类号: C12N7/00 , B82Y5/00 , C12N2770/00023 , D01F1/10 , D01F6/76 , Y10S977/762
摘要: The use of biomaterials, such as viruses and virus-like particles, to form nanostructures is generally disclosed. For instance, rod-like viruses can be used to form composite nanofibers that are fixed together in a head-to-tail assembly by a polymer. Also, 2-dimensional nanostructures formed from crosslinked viruses assembled in a single, film-like layer are generally disclosed. Porous gels having controllable pore size through the use of virus particles are also disclosed.
摘要翻译: 通常公开了使用诸如病毒和病毒样颗粒的生物材料来形成纳米结构。 例如,棒状病毒可以用于形成复合纳米纤维,它们通过聚合物以头对尾组装方式固定在一起。 此外,通常公开了由组装在单个膜状层中的交联病毒形成的二维纳米结构。 还公开了通过使用病毒颗粒具有可控孔径的多孔凝胶。
-
公开(公告)号:US20060188991A1
公开(公告)日:2006-08-24
申请号:US11410572
申请日:2006-04-24
申请人: Alison McCormick , Mark Smith , Kenneth Palmer , John Lindbo , Long Nguyen , Gregory Pogue
发明人: Alison McCormick , Mark Smith , Kenneth Palmer , John Lindbo , Long Nguyen , Gregory Pogue
CPC分类号: C07K14/005 , A61K39/0011 , A61K39/12 , A61K39/385 , A61K2039/5258 , A61K2039/55516 , A61K2039/6075 , A61K2039/627 , A61K2039/64 , C07K14/4748 , C07K2319/00 , C12N7/00 , C12N2710/20022 , C12N2710/20034 , C12N2760/16122 , C12N2760/18022 , C12N2770/00022 , C12N2770/00023
摘要: Herein-described are various methods for making a vaccine that are made of re-assembled virus like particles (VLP). First, the VLPs are disassembled into encapsidation intermediate populations. Each encapsidation intermediate population undergoes, for instance, chemical conjugation of unique peptide or nucleic moieties to form separate populations. Thereafter, a predetermined amount of each of the several (one or more) different encapsidation intermediates from the different populations is mixed and joined, forming intact VLPs, surrounding a nucleic acid core, that are composed of different encapsidation intermediate such that the reassembled VLP displays more than one peptide or nucleic acid. The nucleic acid can function either as a scaffold alone or can be engineered for the expression of an immunomodulatory protein in a eukaryotic cell.
摘要翻译: 本文描述了制备由重组病毒颗粒(VLP)制成的疫苗的各种方法。 首先,将VLP分解成壳化中间种群。 每个壳化中间体经历例如独特的肽或核酸部分的化学共轭以形成分开的群体。 此后,将来自不同群体的几种(一种或多种)不同的壳化中间体中的每一种的预定量混合并连接,形成围绕核酸核心的完整的VLP,其由不同的包封中间体组成,使得重新组装的VLP显示 多于一种肽或核酸。 核酸可以作为单独的支架起作用,或者可以被工程化以在真核细胞中表达免疫调节蛋白。
-
公开(公告)号:US20020192689A1
公开(公告)日:2002-12-19
申请号:US10120013
申请日:2002-04-10
IPC分类号: C12Q001/68
CPC分类号: C12N7/00 , C07K14/005 , C12N15/10 , C12N15/86 , C12N15/88 , C12N2740/16022 , C12N2740/16062 , C12N2740/16222 , C12N2770/00022 , C12N2770/00023 , C12N2770/00042 , C12N2770/34022 , C12N2770/34023 , C12N2770/34042 , C12N2770/36123 , C12N2770/36143 , C12N2795/10122 , C12N2795/10142 , C12N2795/18122 , C12N2795/18123 , C12P19/34 , C12Q1/6851 , C12Q1/702 , C12Q1/706 , C12Q1/707 , C12Q2600/158 , C12Q2545/113
摘要: The present invention relates to nuclease resistant nucleic acids in general and ribonuclease resistant RNAs in particular. Methods of making and using such nucleic acids are disclosed.
摘要翻译: 本发明一般涉及核酸酶抗性核酸,特别涉及核糖核酸酶抗性RNA。 公开了制备和使用这种核酸的方法。
-
公开(公告)号:US20180133304A1
公开(公告)日:2018-05-17
申请号:US15589677
申请日:2017-05-08
IPC分类号: A61K39/12 , A61P35/00 , A61P35/04 , A61K31/704
CPC分类号: A61K39/12 , A61K31/704 , A61K2039/5258 , A61K2039/544 , A61K2039/585 , A61P35/00 , A61P35/04 , C12N7/00 , C12N2770/00023 , C12N2770/00034 , C12N2770/00071 , C12N2770/32022 , C12N2770/32023 , C12N2770/32034 , C12N2770/32071
摘要: A method of treating cancer in a subject in need thereof includes administering in situ to the cancer a therapeutically effective amount of a virus or virus-like particle.
-
公开(公告)号:US08334127B2
公开(公告)日:2012-12-18
申请号:US12883295
申请日:2010-09-16
申请人: Qian Wang , Zhongwei Niu
发明人: Qian Wang , Zhongwei Niu
IPC分类号: C12N7/00
CPC分类号: C12N7/00 , B82Y5/00 , C12N2770/00023 , D01F1/10 , D01F6/76 , Y10S977/762
摘要: The use of biomaterials, such as viruses and virus-like particles, to form nanostructures is generally disclosed. For instance, rod-like viruses can be used to form composite nanofibers that are fixed together in a head-to-tail assembly by a polymer. Also, 2-dimensional nanostructures formed from crosslinked viruses assembled in a single, film-like layer are generally disclosed. Porous gels having controllable pore size through the use of virus particles are also disclosed.
摘要翻译: 通常公开了使用诸如病毒和病毒样颗粒的生物材料来形成纳米结构。 例如,棒状病毒可以用于形成复合纳米纤维,它们通过聚合物以头对尾组装方式固定在一起。 此外,通常公开了由组装在单个膜状层中的交联病毒形成的二维纳米结构。 还公开了通过使用病毒颗粒具有可控孔径的多孔凝胶。
-
公开(公告)号:US08053638B2
公开(公告)日:2011-11-08
申请号:US11835237
申请日:2007-08-07
申请人: Ajith Anand , Kirankumar Mysore
发明人: Ajith Anand , Kirankumar Mysore
CPC分类号: C12N15/8205 , C12N2770/00023
摘要: The invention provides methods and compositions for enhancing the efficiency of Agrobacterium-mediated transformation of host cells such as plant cells. Plant expression constructs comprising a gene encoding a VIP2 or VIP2-like polypeptide are provided, as well as methods for utilizing such constructs to enhance Agrobacterium-mediated transformation efficiency.
摘要翻译: 本发明提供用于提高农杆菌介导的宿主细胞如植物细胞转化效率的方法和组合物。 提供了包含编码VIP2或VIP2样多肽的基因的植物表达构建体,以及利用这些构建体来提高农杆菌介导的转化效率的方法。
-
公开(公告)号:US20110151542A1
公开(公告)日:2011-06-23
申请号:US12883295
申请日:2010-09-16
申请人: Qian Wang , Zhongwei Niu
发明人: Qian Wang , Zhongwei Niu
IPC分类号: C12N7/00
CPC分类号: C12N7/00 , B82Y5/00 , C12N2770/00023 , D01F1/10 , D01F6/76 , Y10S977/762
摘要: The use of biomaterials, such as viruses and virus-like particles, to form nanostructures is generally disclosed. For instance, rod-like viruses can be used to form composite nanofibers that are fixed together in a head-to-tail assembly by a polymer. Also, 2-dimensional nanostructures formed from crosslinked viruses assembled in a single, film-like layer are generally disclosed. Porous gels having controllable pore size through the use of virus particles are also disclosed.
摘要翻译: 通常公开了使用诸如病毒和病毒样颗粒的生物材料来形成纳米结构。 例如,棒状病毒可以用于形成复合纳米纤维,它们通过聚合物以头对尾组装方式固定在一起。 此外,通常公开了由组装在单个膜状层中的交联病毒形成的二维纳米结构。 还公开了通过使用病毒颗粒具有可控孔径的多孔凝胶。
-
公开(公告)号:US20050282263A1
公开(公告)日:2005-12-22
申请号:US11090497
申请日:2005-03-25
申请人: Alison McCormick , Mark Smith , Kenneth Palmer , John Lindbo , Long Nguyen , Gregory Pogue
发明人: Alison McCormick , Mark Smith , Kenneth Palmer , John Lindbo , Long Nguyen , Gregory Pogue
CPC分类号: C12N7/00 , A61K2039/5258 , C12N2710/20022 , C12N2770/00023
摘要: Herein described are various methods for making a vaccine that are made of re-assembled virus like particles (VLP). First, the VLPs are disassembled into coat proteins or encapsidation intermediate populations. Each population undergoes, for instance, chemical conjugation of unique peptide or nucleic moieties to form separate populations. Thereafter, a predetermined amount of each of the several (one or more) different coat proteins or encapsidation intermediates from the different populations is mixed and joined, forming intact VLPs, surrounding a nucleic acid core, that are composed of different coat proteins such that the reassembled VLP displays more than one peptide or other molecule. The nucleic acid can function either as a scaffold alone or can be engineered for the expression of an immunomodulatory protein in a eukaryotic cell.
摘要翻译: 本文描述了制备由重新组装的病毒样颗粒(VLP)制成的疫苗的各种方法。 首先,将VLP分解成外壳蛋白或衣壳化中间种群。 每个群体经历例如独特的肽或核酸部分的化学共轭以形成分开的群体。 此后,将来自不同群体的几种(一种或多种)不同外壳蛋白或壳化中间体中的每一种的预定量混合并连接,形成围绕核酸核心的完整VLP,其由不同的外壳蛋白组成,使得 重组VLP显示多于一个肽或其他分子。 核酸可以作为单独的支架起作用,或者可以被工程化以在真核细胞中表达免疫调节蛋白。
-
公开(公告)号:US5939262A
公开(公告)日:1999-08-17
申请号:US881571
申请日:1997-06-24
IPC分类号: C12N15/09 , C07K14/01 , C12N7/04 , C12N15/10 , C12N15/40 , C12N15/86 , C12N15/88 , C12P19/34 , C12Q1/68 , C12Q1/70 , C07H21/04 , C12N7/00 , C12N15/63
CPC分类号: C12N7/00 , C07K14/005 , C12N15/10 , C12N15/86 , C12N15/88 , C12P19/34 , C12Q1/6851 , C12Q1/702 , C12Q1/706 , C12Q1/707 , C12N2740/16022 , C12N2740/16062 , C12N2740/16222 , C12N2770/00022 , C12N2770/00023 , C12N2770/00042 , C12N2770/34022 , C12N2770/34023 , C12N2770/34042 , C12N2770/36123 , C12N2770/36143 , C12N2795/10122 , C12N2795/10142 , C12N2795/18122 , C12N2795/18123 , C12Q2600/158
摘要: The present invention relates to nuclease resistant nucleic acids in general and ribonuclease resistant RNAs in particular. Methods of making and using such nucleic acids are disclosed.
-
-
-
-
-
-
-
-
-